GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
22 hedge funds and large institutions have $13M invested in GeneDx Holdings Warrant in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$1.76M |
| 2 |
Blackstone Inc
New York
|
+$1.32M |
| 3 |
TCIM
TOMS Capital Investment Management
New York
|
+$888K |
| 4 |
MCM
Moore Capital Management
New York
|
+$838K |
| 5 |
SRCM
Sage Rock Capital Management
New York
|
+$712K |
Top Sellers
WGSWW Hedge Fund Activity: Q4 2020 in Review
22 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q4 2020, worth a combined $13M.
Buyers outnumbered sellers: 22 funds opened new WGSWW positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Linden Advisors, opening a new position worth an estimated $1.76M.
- 22 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $13M of GeneDx Holdings Warrant stock for Q4 2020.
- 22 funds opened new GeneDx Holdings Warrant positions in Q4 2020 and 0 closed out, a net change of +22 holders.
- The largest GeneDx Holdings Warrant buyer in Q4 2020 was Linden Advisors, an estimated $1.76M added.
Based on aggregated 13F filings for Q4 2020.